Overview
| Uniprot ID | O43866 |
| Protein Name | CD5 antigen-like |
| Gene Name | CD5L |
| Organism | Homo sapiens |
Kla Sites from experimental identification
| Position |
Flanking peptide |
| 299 |
SPSFRDRKCYGPGVG |
| 56 |
CDDGWDIKDVAVLCR |
Function
Secreted protein that acts as a key regulator of lipid synthesis: mainly expressed by macrophages in lymphoid and inflamed tissues and regulates mechanisms in inflammatory responses, such as infection or atherosclerosis. Able to inhibit lipid droplet size in adipocytes. Following incorporation into mature adipocytes via CD36-mediated endocytosis, associates with cytosolic FASN, inhibiting fatty acid synthase activity and leading to lipolysis, the degradation of triacylglycerols into glycerol and free fatty acids (FFA). CD5L-induced lipolysis occurs with progression of obesity: participates in obesity-associated inflammation following recruitment of inflammatory macrophages into adipose tissues, a cause of insulin resistance and obesity-related metabolic disease. Regulation of intracellular lipids mediated by CD5L has a direct effect on transcription regulation mediated by nuclear receptors ROR-gamma (RORC). Acts as a key regulator of metabolic switch in T-helper Th17 cells. Regulates the expression of pro-inflammatory genes in Th17 cells by altering the lipid content and limiting synthesis of cholesterol ligand of RORC, the master transcription factor of Th17-cell differentiation. CD5L is mainly present in non-pathogenic Th17 cells, where it decreases the content of polyunsaturated fatty acyls (PUFA), affecting two metabolic proteins MSMO1 and CYP51A1, which synthesize ligands of RORC, limiting RORC activity and expression of pro-inflammatory genes. Participates in obesity-associated autoimmunity via its association with IgM, interfering with the binding of IgM to Fcalpha/mu receptor and enhancing the development of long-lived plasma cells that produce high-affinity IgG autoantibodies (By similarity). Also acts as an inhibitor of apoptosis in macrophages: promotes macrophage survival from the apoptotic effects of oxidized lipids in case of atherosclerosis (PubMed:24295828). Involved in early response to microbial infection against various pathogens by acting as a pattern recognition receptor and by promoting autophagy (PubMed:16030018, PubMed:24223991, PubMed:24583716, PubMed:25713983). Promotes recovery from acute kidney injury (AKI) by accumulating on necrotic cell debris within the kidney proximal tubules following AKI and interacting with HAVCR1 expressed on the surface of injured kidney tubular epithelial cells (PubMed:26726878). This enhances HAVCR1-mediated phagocytosis of intraluminal necrotic debris and contributes to kidney tissue repair (PubMed:26726878). Also enhances necrotic debris uptake by kidney macrophages in a HAVCR1-independent manner (By similarity)
Protein Sequence
10
MALLFSLILA
20
ICTRPGFLAS
30
PSGVRLVGGL
40
HRCEGRVEVE
50
QKGQWGTVCD
60
DGWDIKDVAV
70
LCRELGCGAA
80
SGTPSGILYE
90
PPAEKEQKVL
100
IQSVSCTGTE
110
DTLAQCEQEE
120
VYDCSHDEDA
130
GASCENPESS
140
FSPVPEGVRL
150
ADGPGHCKGR
160
VEVKHQNQWY
170
TVCQTGWSLR
180
AAKVVCRQLG
190
CGRAVLTQKR
200
CNKHAYGRKP
210
IWLSQMSCSG
220
REATLQDCPS
230
GPWGKNTCNH
240
DEDTWVECED
250
PFDLRLVGGD
260
NLCSGRLEVL
270
HKGVWGSVCD
280
DNWGEKEDQV
290
VCKQLGCGKS
300
LSPSFRDRKC
310
YGPGVGRIWL
320
DNVRCSGEEQ
330
SLEQCQHRFW
340
GFHDCTHQED
VAVICSG
Gene Ontology
| Classification |
GO ID |
Description |
| Cellular Component |
GO:0072562 |
blood microparticle |
| Cellular Component |
GO:0009986 |
cell surface |
| Cellular Component |
GO:0005737 |
cytoplasm |
| Cellular Component |
GO:0005576 |
extracellular region |
| Cellular Component |
GO:0005615 |
extracellular space |
| Cellular Component |
GO:0005886 |
plasma membrane |
| Biological Process |
GO:0006915 |
apoptotic process |
| Biological Process |
GO:0006968 |
cellular defense response |
| Biological Process |
GO:0002376 |
immune system process |
| Biological Process |
GO:0006954 |
inflammatory response |
| Biological Process |
GO:0030449 |
regulation of complement activation |
Reference
[1] Hong H, Chen X, Wang H, Gu X, Yuan Y et al.. Global profiling of protein lysine lactylation and potential target modified protein analysis in hepatocellular carcinoma.. Proteomics 23(9):e2200432. 2023 May. PMID: 36625413.